{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T12:46:27Z","timestamp":1794573987192,"version":"4.9.1"},"reference-count":54,"publisher":"SAGE Publications","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"funder":[{"DOI":"10.13039\/501100022606","name":"almirall","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100022606","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005614","name":"biogen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005614","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002491","name":"bristol-myers squibb","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002491","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002907","name":"coloplast","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002907","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004334","name":"merck","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004336","name":"novartis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Mult Scler"],"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>To optimize the care of people with multiple sclerosis in Europe, the European Multiple Sclerosis Platform aimed to gather vital evidence from people with multiple sclerosis to understand prevalence, burden, and symptom management.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>An online survey was distributed by 24 European Multiple Sclerosis Platform\u2013associated multiple sclerosis organizations across 22 countries. Descriptive statistics were applied.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Data from 17,151 people with multiple sclerosis revealed a mean of 13.7 symptoms. The five most prevalent symptoms included fatigue, sensory problems, sleep disturbances, cognitive impairment, and balance problems (range\u2009=\u200975%\u201393%). Respondents utilized a mean of 5.6 concurrent care modalities\/strategies for symptom management, and 86% of them received disease-modifying drugs. They consulted a mean of 4.2 healthcare professionals for symptom management, with 50% experiencing coordination of care. Overall, 50% of respondents expressed satisfaction with their symptom management. However, satisfaction levels varied depending on the specific symptom: people with multiple sclerosis were twice as likely to report satisfaction with managing mobility, bladder control, and spasticity compared to managing sexual problems, fatigue, and cognitive impairment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>This survey provides evidence of the high prevalence, burden, and impact of symptoms in people with multiple sclerosis, highlighting the need for multifaceted care strategies. The results call for a change in healthcare policies and practices.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/13524585261480514","type":"journal-article","created":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T12:13:17Z","timestamp":1788264797000},"update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":1,"title":["Impact of multiple sclerosis symptoms survey: Patient-reported data on the prevalence, burden, and management of multiple sclerosis symptoms in Europe"],"prefix":"10.1177","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5680-5495","authenticated-orcid":false,"given":"Peter","family":"Feys","sequence":"first","affiliation":[{"name":"REVAL Rehabilitation Research Center &amp; UMSC Hasselt-Pelt, UHasselt, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6096-4982","authenticated-orcid":false,"given":"Patricia","family":"Moghames","sequence":"additional","affiliation":[{"name":"European Multiple Sclerosis Platform, Brussels, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth","family":"Kasilingam","sequence":"additional","affiliation":[{"name":"European Multiple Sclerosis Platform, Brussels, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8455-788X","authenticated-orcid":false,"given":"Rachel","family":"King","sequence":"additional","affiliation":[{"name":"Multiple Sclerosis International Federation, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9163-4222","authenticated-orcid":false,"given":"Tommaso","family":"Manacorda","sequence":"additional","affiliation":[{"name":"Italian Multiple Sclerosis Society, Genoa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4432-7959","authenticated-orcid":false,"given":"Magda","family":"Fonseca","sequence":"additional","affiliation":[{"name":"Research and Innovation Department, Portuguese Society of Multiple Sclerosis, Lisbon, Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Rogan","sequence":"additional","affiliation":[{"name":"European Multiple Sclerosis Platform, Dublin, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3566-2269","authenticated-orcid":false,"given":"Daphne","family":"Kos","sequence":"additional","affiliation":[{"name":"Department of Rehabilitation Sciences, KU Leuven, Belgium"},{"name":"National MS Center, Melsbroek, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2026,9,1]]},"reference":[{"key":"e_1_3_3_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(08)61620-7"},{"key":"e_1_3_3_3_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200009283431307"},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)32340-0"},{"key":"e_1_3_3_5_2","doi-asserted-by":"publisher","DOI":"10.1177\/1352458517694432"},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12883-021-02396-1"},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.7224\/1537-2073.2012-053"},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.1177\/17562864211039648"},{"key":"e_1_3_3_9_2","unstructured":"European MS Platform. 2020 MS barometer https:\/\/barometer.ams3.digitaloceanspaces.com\/55ac809262a6e9ad124ecb0dc813d225.pdf"},{"key":"e_1_3_3_10_2","unstructured":"WHO Rehabilitation Competency Framework 2021 https:\/\/www.who.int\/teams\/noncommunicable-diseases\/sensory-functions-disability-and-rehabilitation\/rehabilitation-competency-framework (accessed 21 March 2025)."},{"issue":"1","key":"e_1_3_3_11_2","article-title":"Rehabilitation for people with multiple sclerosis: an overview of cochrane reviews","volume":"1","author":"Amatya B","year":"2019","unstructured":"Amatya B, Khan F, Galea M. Rehabilitation for people with multiple sclerosis: an overview of cochrane reviews. Cochrane Database Syst Rev 2019; 1(1): CD012732.","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.1097\/MRR.0000000000000501"},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.1177\/1352458518807082"},{"key":"e_1_3_3_14_2","doi-asserted-by":"publisher","DOI":"10.1159\/000367620"},{"key":"e_1_3_3_15_2","unstructured":"MS International Federation (MSIF). Atlas of MS https:\/\/www.atlasofms.org\/map\/global\/epidemiology\/number-of-people-with-ms (accessed 21 March 2025)."},{"key":"e_1_3_3_16_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12883-021-02344-z"},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","DOI":"10.1159\/000360423"},{"key":"e_1_3_3_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2018.07.013"},{"key":"e_1_3_3_19_2","doi-asserted-by":"publisher","DOI":"10.3109\/00207454.2012.762364"},{"key":"e_1_3_3_20_2","doi-asserted-by":"publisher","DOI":"10.2196\/jmir.6.3.e34"},{"key":"e_1_3_3_21_2","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2377-13-37"},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/0168-8510(90)90421-9"},{"key":"e_1_3_3_23_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11136-011-9903-x"},{"key":"e_1_3_3_24_2","doi-asserted-by":"publisher","DOI":"10.1080\/23279095.2015.1125905"},{"key":"e_1_3_3_25_2","doi-asserted-by":"publisher","DOI":"10.1177\/1352458518799580"},{"key":"e_1_3_3_26_2","doi-asserted-by":"publisher","DOI":"10.1017\/S1355617722000212"},{"key":"e_1_3_3_27_2","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.1049686"},{"key":"e_1_3_3_28_2","doi-asserted-by":"publisher","DOI":"10.1111\/ene.16234"},{"key":"e_1_3_3_29_2","doi-asserted-by":"publisher","DOI":"10.1177\/1352458520946005"},{"key":"e_1_3_3_30_2","doi-asserted-by":"publisher","DOI":"10.3390\/brainsci11091187"},{"key":"e_1_3_3_31_2","unstructured":"National Institute for Health and Care Excellence. Multiple sclerosis in adults: management (NICE guideline NG220) www.nice.org.uk\/guidance\/ng220 (2022 accessed 28 April 2026)."},{"key":"e_1_3_3_32_2","doi-asserted-by":"crossref","unstructured":"Butzkueven H Giovannoni G Arkelsten S et al. Brain health \u2013 time matters. multiple sclerosis (MS) neuromyelitis optica spectrum disorder (NMOSD) myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) and related conditions https:\/\/www.msbrainhealth.org\/wp-content\/uploads\/2024\/09\/Brain-Health-Time-Matters-2024.pdf (2024 accessed 24 March 2025).","DOI":"10.2139\/ssrn.5183141"},{"key":"e_1_3_3_33_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000207481"},{"key":"e_1_3_3_34_2","unstructured":"US Food and Drug Administration. FDA approves new drug to treat multiple sclerosis 2017 https:\/\/www.fda.Gov\/news-events\/press-announcements\/fda-approves-new-drug-treat-multiple-sclerosis (accessed 24 March 2025)."},{"key":"e_1_3_3_35_2","doi-asserted-by":"publisher","DOI":"10.1111\/ene.13536"},{"key":"e_1_3_3_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2016.04.004"},{"key":"e_1_3_3_37_2","unstructured":"World Health Organization (WHO). WHO endorses landmark public health decisions on essential medicines for multiple sclerosis https:\/\/www.who.int\/news\/item\/26-07-2023-who-endorses-landmark-public-health-decisions-on-essential-medicines-for-multiple-sclerosis (accessed 24 March 2025)."},{"key":"e_1_3_3_38_2","unstructured":"Multiple Sclerosis International Federation. Atlas of MS \u2013 3rd Edition part 2: clinical management of multiple sclerosis around the world https:\/\/www.msif.org\/wp-content\/uploads\/2021\/05\/Atlas-3rd-Edition-clinical-management-report-EN-5-5-21.pdf (2021 accessed 28 April 2026)."},{"key":"e_1_3_3_39_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2026.107112"},{"key":"e_1_3_3_40_2","doi-asserted-by":"publisher","DOI":"10.1111\/ene.16452"},{"key":"e_1_3_3_41_2","unstructured":"National Institute for Health and Care Excellence. Multiple sclerosis in adults: management [B]: evidence reviews for coordination of care: the role of MS nurse specialists and other healthcare professionals (NICE guideline NG220) https:\/\/www.nice.org.uk\/guidance\/ng220\/evidence\/b-coordination-of-care-the-role-of-ms-nurse-specialists-and-other-healthcare-professionals-pdf-11079169600 (2022 accessed 28 April 2026)."},{"key":"e_1_3_3_42_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10072-017-3110-7"},{"key":"e_1_3_3_43_2","unstructured":"World Health Organization (WHO). Landmark resolution on strengthening rehabilitation in health systems 2023 https:\/\/www.who.int\/news\/item\/27-05-2023-landmark-resolution-on-strengthening-rehabilitation-in-health-systems (accessed 24 March 2024)."},{"key":"e_1_3_3_44_2","doi-asserted-by":"publisher","DOI":"10.23736\/S1973-9087.23.08160-1"},{"key":"e_1_3_3_45_2","doi-asserted-by":"crossref","unstructured":"Savio M Kearney H Giunti G. Evaluating the evidence behind multidisciplinary roles for a multiple sclerosis unit: a systematic literature review. Mult Scler Relat Disord 2025; 95: 106342. https:\/\/doi.org\/10.1016\/j.msard.2025.106342","DOI":"10.1016\/j.msard.2025.106342"},{"key":"e_1_3_3_46_2","doi-asserted-by":"crossref","unstructured":"Bahri M Epstein K Stevens E et al. Implementing a multidisciplinary approach for older adults with multiple sclerosis: geriatric neurology in practice. Mult Scler Relat Disord 2024; 92: 105952. https:\/\/doi.org\/10.1016\/j.msard.2024.105952","DOI":"10.1016\/j.msard.2024.105952"},{"key":"e_1_3_3_47_2","doi-asserted-by":"crossref","unstructured":"Van Hijfte L Cambron M Capron B et al. Multiple sclerosis multidisciplinary care: a national survey and lessons for the global community. Mult Scler Relat Disord 2024; 85: 105540. https:\/\/doi.org\/10.1016\/j.msard.2024.105540","DOI":"10.1016\/j.msard.2024.105540"},{"key":"e_1_3_3_48_2","doi-asserted-by":"crossref","unstructured":"Pastore F Sanchez MAR Harrison CM et al. The clinical nurse practitioner\u2019s essential role in early diagnosis and management of multiple sclerosis in Europe: a consensus report. Int J MS Care 2024; 26(Q3): 208\u2013213. https:\/\/doi.org\/10.7224\/1537-2073.2023-070","DOI":"10.7224\/1537-2073.2023-070"},{"key":"e_1_3_3_49_2","doi-asserted-by":"crossref","unstructured":"Smyth P Watson KE Al Hamarneh YN et al. The effect of nurse practitioner (NP-led) care on health-related quality of life in people with multiple sclerosis\u2013a randomized trial. BMC Neurol 2022; 22(1): 275. https:\/\/doi.org\/10.1186\/s12883-022-02809-9","DOI":"10.1186\/s12883-022-02809-9"},{"key":"e_1_3_3_50_2","doi-asserted-by":"crossref","unstructured":"Yal\u00e7\u0131n GY Tulek Z K\u00fcrt\u00fcnc\u00fc M. Effect of a nurse-led online patient support program on fatigue sleep and quality of life in patients with multiple sclerosis: a quasi-experimental study. BMC Neurol 2025; 25(1): 238. https:\/\/doi.org\/10.1186\/s12883-025-04248-8","DOI":"10.1186\/s12883-025-04248-8"},{"key":"e_1_3_3_51_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12955-022-02046-1"},{"key":"e_1_3_3_52_2","doi-asserted-by":"crossref","unstructured":"Herrera-Rojas A Moreno-Molina A Garc\u00eda-Garc\u00eda E et al. Effects of telerehabilitation platforms on quality of life in people with multiple sclerosis: a systematic review of randomized clinical trials. Neurosci 2025; 6(4): 103. https:\/\/doi.org\/10.3390\/neurosci6040103","DOI":"10.3390\/neurosci6040103"},{"key":"e_1_3_3_53_2","doi-asserted-by":"crossref","unstructured":"Xiang XM Bernard J. Telehealth in multiple sclerosis clinical care and research. Curr Neurol Neurosci Rep 2021; 21(4): 14. https:\/\/doi.org\/10.1007\/s11910-021-01103-4","DOI":"10.1007\/s11910-021-01103-4"},{"key":"e_1_3_3_54_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2023.104958"},{"key":"e_1_3_3_55_2","doi-asserted-by":"publisher","DOI":"10.2217\/nmt-2018-0046"}],"container-title":["Multiple Sclerosis Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/13524585261480514","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/13524585261480514","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/13524585261480514","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T18:01:49Z","timestamp":1788458509000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/13524585261480514"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,1]]},"references-count":54,"alternative-id":["10.1177\/13524585261480514"],"URL":"https:\/\/doi.org\/10.1177\/13524585261480514","relation":{},"ISSN":["1352-4585","1477-0970"],"issn-type":[{"value":"1352-4585","type":"print"},{"value":"1477-0970","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,1]]},"article-number":"13524585261480514"}}